Profile data is unavailable for this security.
About the company
Outset Medical, Inc. is a medical technology company. The Company offers Tablo Hemodialysis System (Tablo), which is a single enterprise solution for hemodialysis, comprised of a compact console with integrated water purification, on-demand dialysate production and advanced software and connectivity capabilities. The Company designed Tablo from the ground up to be a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by virtually anyone. The Tablo system comprises components, which include Tablo Console, Tablo Cartridge and Tablo Data Ecosystem. Tablo Console is a compact, mobile and versatile machine consisting of an integrated water purification, on-demand dialysate production system and touchscreen interface with 3D animations. It also offers various key platforms, such as TabloHub, a customer-facing portal; MyTablo, a patient-facing portal, and TabloDash, an internal data analytics platform.
- Revenue in USD (TTM)125.08m
- Net income in USD-168.77m
- Incorporated2003
- Employees480.00
- LocationOutset Medical Inc3052 Orchard DriveSAN JOSE 95134United StatesUSA
- Phone+1 (971) 563-3083
- Fax+1 (302) 655-5049
- Websitehttps://outsetmedical.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| InfuSystem Holdings Inc | 127.41m | 84.00k | 137.14m | 499.00 | 2,316.55 | 2.62 | 11.16 | 1.08 | 0.0028 | 0.0028 | 5.91 | 2.46 | 1.23 | 10.66 | 6.57 | 255,330.70 | 0.0811 | 4.60 | 0.0955 | 5.69 | 50.27 | 56.43 | 0.0659 | 4.07 | 1.51 | 1.56 | 0.3641 | 0.00 | 14.44 | 13.38 | 4,744.44 | -- | 6.01 | -- |
| Akoya Biosciences Inc | 93.57m | -68.01m | 140.62m | 330.00 | -- | 4.30 | -- | 1.50 | -1.47 | -1.47 | 1.99 | 0.6632 | 0.6056 | 2.20 | 7.08 | 283,554.50 | -44.01 | -- | -56.06 | -- | 55.99 | -- | -72.68 | -- | 2.38 | -10.15 | 0.7013 | -- | 29.09 | -- | 10.36 | -- | -- | -- |
| Electromed Inc | 53.50m | 4.36m | 141.78m | 170.00 | 33.14 | 3.33 | 27.39 | 2.65 | 0.4942 | 0.4942 | 6.08 | 4.92 | 1.17 | 3.31 | 2.25 | 314,682.30 | 9.49 | 7.86 | 11.03 | 9.14 | 76.41 | 76.25 | 8.14 | 7.38 | 5.87 | -- | 0.00 | 0.00 | 15.38 | 11.17 | 37.35 | 11.00 | 24.58 | -- |
| TELA Bio Inc | 63.15m | -40.30m | 154.83m | 227.00 | -- | 10.76 | -- | 2.45 | -1.67 | -1.67 | 2.61 | 0.5834 | 0.9668 | 1.37 | 7.60 | 278,180.60 | -61.70 | -52.00 | -79.77 | -60.95 | 68.97 | 65.32 | -63.82 | -107.65 | 3.23 | -8.52 | 0.7387 | -- | 41.13 | 47.85 | -5.35 | -- | -17.12 | -- |
| Accuray Inc | 430.55m | -21.49m | 161.77m | 1.02k | -- | 3.94 | -- | 0.3757 | -0.2197 | -0.2197 | 4.42 | 0.4139 | 0.9178 | 1.86 | 5.72 | 420,462.90 | -4.58 | -1.45 | -7.84 | -2.48 | 33.06 | 37.86 | -4.99 | -1.62 | 0.778 | -0.3857 | 0.8086 | -- | 4.12 | 2.03 | -73.56 | -- | 13.92 | -- |
| Semler Scientific Inc | 65.88m | 21.69m | 162.58m | 92.00 | 8.28 | 2.04 | 7.28 | 2.47 | 2.78 | 2.78 | 8.45 | 11.26 | 0.855 | 15.13 | 8.51 | 716,097.80 | 28.14 | 38.83 | 31.14 | 44.41 | 89.43 | 90.22 | 32.92 | 32.58 | 12.11 | -- | 0.00 | -- | 20.28 | 25.98 | 43.69 | 32.64 | -0.3821 | -- |
| Clearpoint Neuro Inc | 26.16m | -20.63m | 170.01m | 107.00 | -- | 4.92 | -- | 6.50 | -0.8326 | -0.8326 | 1.05 | 1.26 | 0.5037 | 1.26 | 10.08 | 244,495.30 | -39.71 | -34.75 | -49.90 | -39.67 | 57.10 | 64.75 | -78.84 | -76.91 | 2.61 | -- | 0.2237 | -- | 16.56 | 26.64 | -34.40 | -- | 75.30 | -- |
| Stereotaxis Inc | 27.10m | -21.22m | 172.47m | 122.00 | -- | 11.84 | -- | 6.36 | -0.2575 | -0.2575 | 0.3288 | 0.2439 | 0.6012 | 1.45 | 6.14 | 222,155.70 | -44.08 | -25.02 | -63.05 | -34.12 | 55.16 | 67.57 | -73.32 | -41.90 | 1.79 | -- | 0.00 | -- | -4.89 | -1.82 | -12.33 | -- | 6.63 | -- |
| CVRx Inc | 42.09m | -52.01m | 179.03m | 200.00 | -- | 2.70 | -- | 4.25 | -2.48 | -2.48 | 2.01 | 3.07 | 0.3678 | 0.6781 | 5.64 | 210,430.00 | -45.45 | -- | -48.95 | -- | 84.45 | -- | -123.58 | -- | 10.87 | -21.11 | 0.3064 | -- | 74.89 | -- | 0.5528 | -- | -- | -- |
| Orchestra Biomed Holdings Inc | 2.22m | -51.64m | 186.45m | 56.00 | -- | 3.26 | -- | 84.14 | -1.47 | -1.47 | 0.063 | 1.60 | 0.0203 | 1.01 | 30.99 | 39,571.43 | -47.18 | -- | -52.58 | -- | 92.06 | -- | -2,330.46 | -- | 7.33 | -- | 0.00 | -- | -21.88 | -- | -37.91 | -- | -- | -- |
| Outset Medical Inc | 125.08m | -168.77m | 186.64m | 480.00 | -- | 2.00 | -- | 1.49 | -3.38 | -3.38 | 2.50 | 1.80 | 0.3529 | 1.82 | 3.53 | 260,577.10 | -47.61 | -41.40 | -54.98 | -47.29 | 24.61 | 5.71 | -134.93 | -159.05 | 5.32 | -32.13 | 0.6786 | -- | 13.00 | 130.43 | -6.04 | -- | 14.27 | -- |
| Inogen Inc | 321.52m | -96.68m | 208.19m | 834.00 | -- | 1.08 | -- | 0.6475 | -4.15 | -4.15 | 13.81 | 8.15 | 0.917 | 6.03 | 6.83 | 385,519.20 | -27.57 | -8.23 | -34.28 | -9.53 | 40.54 | 44.54 | -30.07 | -10.31 | 2.36 | -- | 0.00 | -- | -16.32 | -2.49 | -22.30 | -- | 26.34 | -- |
| Delcath Systems Inc | 4.61m | -49.79m | 210.33m | 76.00 | -- | 13.17 | -- | 45.65 | -2.65 | -2.65 | 0.2357 | 0.5747 | 0.1382 | 0.4545 | 4.56 | 60,618.42 | -149.30 | -116.57 | -249.28 | -243.21 | 70.54 | 71.02 | -1,080.73 | -1,235.37 | 2.25 | -42.25 | 0.3348 | -- | -24.05 | -9.53 | -30.60 | -- | -5.26 | -- |
| Butterfly Network Inc | 68.08m | -121.92m | 217.03m | 225.00 | -- | 1.06 | -- | 3.19 | -0.5893 | -0.5893 | 0.329 | 0.9685 | 0.2045 | 0.6954 | 4.97 | 302,577.80 | -36.61 | -- | -42.07 | -- | 26.50 | -- | -179.08 | -- | 3.34 | -- | 0.00 | -- | -10.21 | -- | 20.76 | -- | -- | -- |
| Neuropace Inc | 69.07m | -31.51m | 235.04m | 171.00 | -- | 16.36 | -- | 3.40 | -1.18 | -1.18 | 2.59 | 0.4994 | 0.6735 | 1.62 | 6.63 | 403,935.70 | -30.72 | -- | -34.60 | -- | 73.97 | -- | -45.61 | -- | 5.56 | -4.67 | 0.8019 | -- | 43.72 | -- | 30.00 | -- | -- | -- |
Data as of May 17 2024. Currency figures normalised to Outset Medical Inc's reporting currency: US Dollar USD
57.74%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Fidelity Management & Research Co. LLCas of 31 Mar 2024 | 6.75m | 13.36% |
| Columbia Wanger Asset Management LLCas of 31 Mar 2024 | 3.60m | 7.13% |
| Morgan Stanley & Co. LLCas of 31 Mar 2024 | 3.55m | 7.02% |
| BlackRock Fund Advisorsas of 31 Mar 2024 | 3.03m | 6.01% |
| The Vanguard Group, Inc.as of 31 Mar 2024 | 2.80m | 5.53% |
| JPMorgan Investment Management, Inc.as of 31 Mar 2024 | 2.44m | 4.83% |
| Braidwell LPas of 31 Mar 2024 | 2.40m | 4.75% |
| D. E. Shaw & Co. LPas of 31 Mar 2024 | 1.69m | 3.34% |
| Ensign Peak Advisors, Inc.as of 31 Mar 2024 | 1.60m | 3.18% |
| Threadneedle Asset Management Ltd.as of 31 Mar 2024 | 1.31m | 2.60% |
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
